Petros Pharmaceuticals, Inc. Warrants and Rights Outstanding
Petros Pharmaceuticals, Inc. (PTPI) had Warrants and Rights Outstanding of $900 as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2026-08-13
- 2026-03-31: Warrants and Rights Outstanding $900.00.
- 2025-12-31: Warrants and Rights Outstanding $900.00.
- 2025-09-30: Warrants and Rights Outstanding $2.60K.
- 2025-06-30: Warrants and Rights Outstanding $3.60K.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2026-03-31 | $900.00 10-Q · filed 2026-05-13 |
| 2025-12-31 | $900.00 10-Q · filed 2026-08-13 |
| 2025-09-30 | $2.60K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $3.60K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $8.29M 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |